Series A - Eyenuk

Series A - Eyenuk

Investment Firm

Overview

Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.

Announced Date

Oct 17, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

AXA Investment Managers

AXA Investment Managers

No designation

Participant Investors

2

Investor Name
Participant InvestorKendall Capital Partners
Participant InvestorAXA Investment Managers

Round Details and Background

Eyenuk raised $26000000 on 2022-10-17 in Series A

Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 20, 2021
Venture Round - Eyenuk
2-6.2M
Jun 01, 2018
Grant - Eyenuk
-1.8M
Oct 17, 2022
Series A - Eyenuk
5-26.0M
Jul 22, 2016
Seed Round - Eyenuk
-1.5M

Recent Activity

There is no recent news or activity for this profile.